Development Level

Tbio 4 | 10,625

Disease

Endometriosis 3 | 535
Acromegaly 2 | 40
Adenoma 2 | 165
Amenorrhea 2 | 60
Bradycardia 2 | 24
Catalepsy 2 | 15
Cushing's syndrome 2 | 47
Empty sella syndrome 2 | 6
Hyperprolactinemia 2 | 22
Hyperthyroidism 2 | 50
Hypoglycemia 2 | 81
Hypogonadism 2 | 70
Hypopituitarism 2 | 36
Hypothyroidism 2 | 89
Kidney disease 2 | 397
Klinefelter's syndrome 2 | 59
Nelson syndrome 2 | 6
Obesity 2 | 616
Pituitary adenoma 2 | 35
glioblastoma 2 | 5,572
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,289
pancreatic cancer 2 | 2,300
pituitary cancer 2 | 1,972
primary pancreatic ductal adenocarcinoma 2 | 1,271
primitive neuroectodermal tumor 2 | 3,031
Adenocarcinoma 1 | 115
Adult T-cell leukemia 1 | 5
Alcohol dependence 1 | 107
Amnesia 1 | 17
Anemia 1 | 252
Animal Mammary Neoplasms 1 | 136
Anorexia nervosa 1 | 59
Anovulation 1 | 20
Anxiety disorder 1 | 22
Aortic valve calcification 1 | 3
Asphyxiating thoracic dystrophy 1 | 34
Autistic Disorder 1 | 320
Barrett's esophagus 1 | 185
Basal Ganglia Diseases 1 | 12
Basal ganglia calcification 1 | 17
Bone lymphoma 1 | 3
Brain disease 1 | 84
Breast disease 1 | 8
Cardiac arrhythmia 1 | 26
Ciliopathy 1 | 57
Craniopharyngioma 1 | 13
Eating disorder 1 | 24
Endometriosis of uterus 1 | 3
Erectile dysfunction 1 | 10
Female infertility 1 | 28
Fetal Resorption 1 | 1
Fever 1 | 34
Gastroenteritis 1 | 46
Goiter 1 | 27
Growth Hormone-Secreting Pituitary Adenoma 1 | 5
Gynecomastia 1 | 13
Heart failure 1 | 80
Hyperparathyroidism 1 | 43
Hyperphosphatemia 1 | 32
Hypotension 1 | 53
Hypothalamic disease 1 | 3
Hypothermia, natural 1 | 12
Infarction 1 | 2
Jeune thoracic dystrophy 1 | 9
Learning Disorders 1 | 27
Leukemia, Myelocytic, Acute 1 | 113
Leydig cell tumor 1 | 9
Lupus Erythematosus, Systemic 1 | 73
Mainzer-Saldino Disease 1 | 2
Major Depressive Disorder 1 | 106
Mammary Neoplasms, Experimental 1 | 150
McCune Albright syndrome 1 | 19
Melancholia 1 | 12
Multiple Endocrine Neoplasia Type 1 1 | 30
Narcolepsy 1 | 69
Ovarian dysfunction 1 | 19
Paget's disease of bone 1 | 28
Pain 1 | 70
Pain agnosia 1 | 99
Parkinsonian Disorders 1 | 23
Peripartum cardiomyopathy 1 | 4
Pituitary Neoplasms 1 | 6
Pituitary apoplexy 1 | 3
Pituitary-dependent Cushing's disease 1 | 8
Pregnancy Complications, Cardiovascular 1 | 4
Prolactinoma 1 | 4
Pseudohypoparathyroidism 1 | 17
Psychosexual Disorders 1 | 6
Respiratory Insufficiency 1 | 11
Retinitis pigmentosa 1 | 156
Sensenbrenner syndrome 1 | 15
Sexual dysfunction 1 | 10
Stereotypic movement disorder 1 | 6
Substance Withdrawal Syndrome 1 | 55
Tachycardia 1 | 17
Thyroiditis 1 | 25
Thyrotoxicosis 1 | 38
Varicocele 1 | 21
active ulcerative colitis 1 | 477
systemic lupus erythematosus 1 | 172

Tissue

Blood and immune system 4 | 17,995
Cardiovascular System 4 | 17,958
Digestive Tract 4 | 18,473
Endocrine System 4 | 18,512
Female tissues 4 | 18,647
Liver and Pancreas 4 | 18,136
Male tissues 4 | 17,969
Nervous System 4 | 18,561
Respiratory system 4 | 17,484
Skin and soft tissues 4 | 18,115
Urinary Tract 4 | 18,444

Target Family

Non-IDG 3 | 11,969
Transporter 1 | 473

Grant Application

5R01DK040339-17 4 | 4
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Sodium-dependent phosphate transporter 1 SLC20A1 Tbio Transporter -1.76184 51.2 87
Prolactin PRL Tbio Non-IDG -3.97831 9998.4 963
Pro-thyrotropin-releasing hormone TRH Tbio Non-IDG -3.25140 1859.6 98
Intraflagellar transport protein 172 homolog IFT172 Tbio Non-IDG -2.46888 279.6 59